Kestra Advisory Services LLC raised its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 3,561.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 62,246 shares of the company’s stock after acquiring an additional 60,546 shares during the period. Kestra Advisory Services LLC’s holdings in BlackRock Health Sciences Term Trust were worth $894,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in the stock. Kathmere Capital Management LLC bought a new position in shares of BlackRock Health Sciences Term Trust in the 1st quarter worth $182,000. Apollon Wealth Management LLC increased its holdings in BlackRock Health Sciences Term Trust by 27.8% in the first quarter. Apollon Wealth Management LLC now owns 60,197 shares of the company’s stock valued at $864,000 after purchasing an additional 13,102 shares during the last quarter. Janney Montgomery Scott LLC increased its holdings in BlackRock Health Sciences Term Trust by 7.5% in the first quarter. Janney Montgomery Scott LLC now owns 28,135 shares of the company’s stock valued at $404,000 after purchasing an additional 1,966 shares during the last quarter. TrueMark Investments LLC lifted its stake in BlackRock Health Sciences Term Trust by 21.9% in the first quarter. TrueMark Investments LLC now owns 59,196 shares of the company’s stock valued at $850,000 after buying an additional 10,629 shares during the period. Finally, RFG Advisory LLC lifted its stake in BlackRock Health Sciences Term Trust by 3,118.4% in the first quarter. RFG Advisory LLC now owns 25,200 shares of the company’s stock valued at $362,000 after buying an additional 24,417 shares during the period.
BlackRock Health Sciences Term Trust Stock Performance
Shares of BMEZ opened at $15.32 on Friday. BlackRock Health Sciences Term Trust has a 1 year low of $13.67 and a 1 year high of $15.80. The stock’s 50-day moving average price is $14.82 and its two-hundred day moving average price is $14.73.
BlackRock Health Sciences Term Trust Dividend Announcement
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.
The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.
Read More
- Five stocks we like better than BlackRock Health Sciences Term Trust
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
